- Home
- THAR vs SQFT Comparison
THAR vs SQFT Comparison
Compare THAR & SQFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- SQFT
- Stock Information
- Founded
- THAR 2017
- SQFT 1999
- Country
- THAR United States
- SQFT United States
- Employees
- THAR N/A
- SQFT N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- SQFT Real Estate Investment Trusts
- Sector
- THAR Health Care
- SQFT Real Estate
- Exchange
- THAR Nasdaq
- SQFT Nasdaq
- Market Cap
- THAR 5.5M
- SQFT 6.2M
- IPO Year
- THAR 2022
- SQFT 2020
- Fundamental
- Price
- THAR $1.82
- SQFT $5.59
- Analyst Decision
- THAR Strong Buy
- SQFT
- Analyst Count
- THAR 1
- SQFT 0
- Target Price
- THAR $17.00
- SQFT N/A
- AVG Volume (30 Days)
- THAR 45.3K
- SQFT 13.0K
- Earning Date
- THAR 08-08-2025
- SQFT 08-13-2025
- Dividend Yield
- THAR N/A
- SQFT N/A
- EPS Growth
- THAR N/A
- SQFT N/A
- EPS
- THAR N/A
- SQFT N/A
- Revenue
- THAR N/A
- SQFT $18,260,398.00
- Revenue This Year
- THAR N/A
- SQFT $23.63
- Revenue Next Year
- THAR N/A
- SQFT N/A
- P/E Ratio
- THAR N/A
- SQFT N/A
- Revenue Growth
- THAR N/A
- SQFT N/A
- 52 Week Low
- THAR $0.95
- SQFT $4.19
- 52 Week High
- THAR $6.39
- SQFT $8.77
- Technical
- Relative Strength Index (RSI)
- THAR 62.50
- SQFT 61.18
- Support Level
- THAR $1.30
- SQFT $4.29
- Resistance Level
- THAR $1.46
- SQFT $4.57
- Average True Range (ATR)
- THAR 0.15
- SQFT 0.29
- MACD
- THAR 0.05
- SQFT 0.15
- Stochastic Oscillator
- THAR 79.41
- SQFT 88.61
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.